The clinical correlates of serum CA125 in 169 patients with epithelial ovarian carcinoma | Zendy

RE Hawkins | Zendy; K. Roberts | Zendy; E. Wiltshaw | Zendy; J. N. Mundy | Zendy; V. R. McCready | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

The clinical correlates of serum CA125 in 169 patients with epithelial ovarian carcinoma

Author(s) -

RE Hawkins,

K. Roberts,

E. Wiltshaw,

J. N. Mundy,

V. R. McCready

Publication year - 1989

Publication title -

british journal of cancer

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.833

H-Index - 236

eISSN - 1532-1827

pISSN - 0007-0920

DOI - 10.1038/bjc.1989.329

Subject(s) - ovarian carcinoma , medicine , chemotherapy , oncology , epithelial ovarian carcinoma , carcinoma , disease , ovarian cancer , epithelial ovarian cancer , pathology , gastroenterology , cancer

Serial CA125 measurements in 169 patients with epithelial ovarian carcinoma were obtained. Changes in serum CA125 measurements are shown to reflect changes in clinical status. For patients with macroscopic disease receiving chemotherapy, the sensitivity and specificity for predicting response are shown to be 95% and 86% respectively. For patients with no known disease, the sensitivity and specificity for detecting relapse are shown to be 86% and 91% respectively. The clinical correlates with the level of serum CA125 were examined and the most important is shown to be amount of residual disease.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research